ATAXIN2 CAG-repeat length in Italian patients with amyotrophic lateral sclerosis: risk factor or variant phenotype? Implication for genetic testing and counseling

作者：Gellera Cinzia; Ticozzi Nicola; Pensato Viviana; Nanetti Lorenzo; Castucci Alessia; Castellotti Barbara; Lauria Giuseppe; Taroni Franco; Silani Vincenzo; Mariotti Caterina^*

来源：Neurobiology of Aging, 2012, 33(8): 1847.e15.

DOI：10.1016/j.neurobiolaging.2012.02.004

• Spinocerebellar ataxia type 2
• Ataxin 2
• ATXN2
• Amyotrophic lateral sclerosis
• Neurodegenerative disorders
• Triplet repeats
• CAG
• Polyglutamine disorders

Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disease mainly involving cortical and spinal motor neurons. Several studies indicated that intermediate CAG expansions in ataxin-2 gene (ATXN2) are associated with increased risk of ALS. We analyzed ATXN2 CAG repeats in 658 sporadic ALS patients (SALS), 143 familial ALS cases (FALS), 231 sporadic ataxic subjects, and 551 control subjects. The frequency of ATXN2 alleles with 27-30 repeats was similar in SALS and control subjects. Fifteen SALS subjects carried %26gt;= 31 CAG repeats. This difference was statistically significant (p = 0.0014). No alleles with %26gt;= 34 CAG were found. In FALS, the distribution of ATXN2 alleles was similar to control subjects. Our results further contributed in refining CAG-repeat range significantly associated with sporadic ALS. Literature data and our findings indicate that only alleles with %26gt;= 31 CAG may represent low-penetrance disease/susceptibility alleles associated with variable neurodegenerative phenotypes, including cerebellar ataxia, parkinsonism, and ALS. Overlapping phenotypes should be considered in genetic testing and counseling, both for patients and at-risk family members.

• 出版日期2012-8